Genetic Test Indications and Interpretations in Patients With Hereditary Angioedema

Weller, Catherine R.; van Dellen, Richard G.
July 2006
Mayo Clinic Proceedings;Jul2006, Vol. 81 Issue 7, p958
Academic Journal
Patients with hereditary angioedema (HAE) present with recurrent, circumscribed, and self-limiting episodes of tissue or mucous membrane swelling caused by C1-inhibitor (C1-INH) deficiency. The estimated frequency of HAE is 1:50,000 persons. Distinguishing HAE from acquired angioedema (AAE) facilitates therapeutic interventions and family planning or testing. Patients with HAE benefit from treatment with attenuated androgen, antifibrinolytic agents, and C1-INH concentrate replacement during acute attacks. HAE is currently recognized as a genetic disorder with autosomal dominant transmission. Other forms of inherited angioedema that are not associated with genetic mutations have also been identified. Readily available tests are complement studies, including C4 and C1-esterase inhibitor, both antigenic and functional C1-INH. These are the most commonly used tests in the diagnosis of HAE. Analysis of C1q can help differentiate between HAE and AAE caused by C1-INH deficiency. Genetic tests would be particularly helpful in patients with no family history of angioedema, which occurs in about half of affected patients, and in patients whose C1q level is borderline and does not differentiate between HAE and AAE. Measuring autoantibodies against C1-INH also would be helpful, but the test is available in research laboratories only. Simple complement determinations are appropriate for screening and diagnosis of the disorder.


Related Articles

  • Is genetic screening for the Lynch syndrome effective? Misak, Aleksandra // CMAJ: Canadian Medical Association Journal;6/7/2005, Vol. 172 Issue 12, p1557 

    Discusses research being done on the effectiveness of genetic screening for the Lynch syndrome. Reference to a study by H. Hampel et al, published in the 2005 issue of the "New England Journal of Medicine"; Background of the research; Results; Practice implications.

  • Editorial: The shifting nature of genome scans.  // New Scientist;8/1/2009, Vol. 203 Issue 2719, p3 

    The authors comment on the nature of genome scans or genetic screening. They relate how a genome scan can motivate a person to take the steps necessary to prevent a disease. Information is presented on the importance of environmental factors like diet and exercise in determining who succumbs to...

  • Clinical utility gene card for: Dyskeratosis congenita. Dokal, Inderjeet; Vulliamy, Tom; Mason, Philip; Bessler, Monica // European Journal of Human Genetics;Nov2011, Vol. 19 Issue 11, p1 

    The article offers information on genetic testing for dyskeratosis congenital (DC). It presents a series of questions that should be answered prior to the administration of genetic testing which include the effect of disease management to test result, effect of the test result to lifestyle and...

  • Asymptomatic proteinuria, renal cysts and dorsal pancreas agenesis. Lim, Cynthia C.; Lai, Angeline H.M.; Choo, Jason C.J. // Clinical Kidney Journal;Aug2014, Vol. 7 Issue 4, p411 

    The article presents a case study of 28-year-old woman with no significant past medical history and no family history of diabetes mellitus or kidney disease. Physical examination found mild cortical scarring in the upper pole of the right kidney but no hydronephrosis. Clinical findings suggested...

  • ANALYZING ILLUMINA HUMAN 1M SNP DATA FOR CNVS USING RAW BEAD-LEVEL DATA. Shah, Naisha; Conroy, Judith; Regan, Regina; Ennis, Sean; Shields, Denis C. // Ulster Medical Journal;2009, Vol. 78 Issue 1, p67 

    With the advent of high-throughput genotyping chips, whole genome association studies are undertaken to determine potential candidate loci by linking common SNPs and copy number variations to human disorders like autism. Illumina's Human 1M SNP beadchip is one of the high-throughput genotyping...

  • Patient accounts of diagnostic testing for familial hypercholesterolaemia: comparing responses to genetic and non-genetic testing methods. Hollands, Gareth J.; Armstrong, David; Macfarlane, Angela; Crook, Martin A.; Marteau, Theresa M. // BMC Medical Genetics;2012, Vol. 13 Issue 1, p87 

    Background: Continuing developments in genetic testing technology together with research revealing gene-disease associations have brought closer the potential for genetic screening of populations. A major concern, as with any screening programme, is the response of the patient to the findings of...

  • Poster presentations: 1. Clinical Genetics/Counselling.  // Journal of Medical Genetics;Sep2002 Supplement, Vol. 39, pS36 

    Discusses the abstract of the research paper entitled 'Diagnosing the future,' by Trevor Cole, J.E.V. Morton et al and presented during the British Human Genetics Conference at the University of York in England in September 2002.

  • Poster presentations: 3. Molecular Genetics.  // Journal of Medical Genetics;Sep2002 Supplement, Vol. 39, pS77 

    Discusses the abstract of the research paper entitled 'A diagnostic service for detection of DM2 expansion mutations,' by David Cockburn, A.C. Sharpe et al and presented during the British Human Genetics Conference at the University of York in England in September 2002.

  • Genetic association studies: Web-based resources for effective screening and assessment of candidate genes and pathways. Soranzo, Nicole // Human Genomics;May2004, Vol. 1 Issue 4, p307 

    The increased availability of polymorphism resources for humans and high-throughput genotyping technologies account for the large number of genetic associations published every month. Resources that allow one to synthesise published data quickly and effectively are needed to keep up to date with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics